Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1951 DPC-681Summary: DPC-681 is a potent and selective HIVprotease inhibitor. -
BA1952 4-Deoxy-4α-phorbolSummary: 4-Deoxy-4α-phorbol is a tetracyclic diterpene. -
BA1953 PirmitegravirSummary: Pirmitegravir is a potent, first-in-class inhibitor targeting the LEDGF/p75 binding site. -
BA1954 ZinlirvimabSummary: Zinlirvimab is a human IgG1-λ2 neutralizing antibody. -
BA1955 IMB-301Summary: IMB-301 is a specific replication inhibitor. -
BA1956 AtevirdineSummary: Atevirdine is a potent non-nucleoside HIV-1 reverse transcriptase inhibitor. -
BA1957 NipamovirSummary: Nipamovir is a nitroimidazole prodrug. -
BA1958 PeldesineSummary: Peldesine (BCX34) is a potent, competitive, reversible and orally active purine nucleoside phosphorylase inhibitor. -
BA1959 AzddMeCSummary: AzddMeC (CS-92) is an antiviral nucleoside analog and a potent, selective, orally active inhibitor of reverse transcriptase and replication. -
BA1960 ElipovimabSummary: Elipovimab is a potent broadly neutralizing HIV-1 antibody for targeting and eliminating infected cells.

